Showing 3491-3500 of 18631 results for "".
Advances in MS Management: Current and Future Directions
https://reachmd.com/programs/neurofrontiers/advances-in-ms-management-current-and-future-directions/26387/Read about a recent review article that provided critical insights on the pathophysiology, diagnosis, and treatment of multiple sclerosis.Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
https://reachmd.com/programs/cme/tbd/36194/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Expert Recommendations and Key Takeaways
https://reachmd.com/programs/cme/expert-recommendations-and-key-takeaways/36186/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Heart Failure Grand Rounds: 3 Things You Need to Know About Cardiac Contractility Modulation
https://reachmd.com/programs/cme/heart-failure-grand-rounds-3-things-you-need-to-know-about-cardiac-contractility-modulation/14396/What can you do when GDMT isn’t working? Learn about CCM, an implantable device-based therapy that’s improving symptoms and QoL in patients with HF.How NEMLUVIO® Works
https://reachmd.com/programs/nemluvio-peer-network/how-nemluvio-works/37226/Learn how NEMLUVIO® works to directly block IL-31RA from Dr Peter Lio, a leading dermatologist, with extensive experience in treating neuroimmune skin diseases.FSGS in Practice: Patient-Centered Decision-Making
https://reachmd.com/programs/cme/fsgs-in-practice-patient-centered-decision-making/35713/Join our expert nephrology faculty and learn about practical strategies for improving your diagnostic skills and treatment selection in FSGS.Future Directions in Managing Hyperkalemia in CKD and HF
https://reachmd.com/programs/cme/tbd/37676/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
https://reachmd.com/programs/cme/tbd/37675/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Molecular Magic: Decoding the Unique Mechanism of CELMoDs
https://reachmd.com/programs/cme/molecular-magic-decoding-the-unique-mechanism-of-celmods/36562/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivityData Dive: Clinical Evidence Behind CELMoDs
https://reachmd.com/programs/cme/data-dive-clinical-evidence-behind-celmods/36568/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma Activity